Literature DB >> 31978841

Nanoscale pathways for human tooth decay - Central planar defect, organic-rich precipitate and high-angle grain boundary.

Fan Yun1, Michael V Swain2, Hansheng Chen1, Julie Cairney3, Jiangtao Qu1, Gang Sha4, Hongwei Liu5, Simon P Ringer6, Yu Han7, Lingmei Liu7, Xixiang Zhang7, Rongkun Zheng8.   

Abstract

Understanding the pathways and mechanisms of human tooth decay is central to the development of both prophylaxes and treatments, but only limited information is presently available about the initiation of caries at the nanoscale. By combining atom probe tomography and high-resolution electron microscopy, we have found three distinct initial sites for human dental enamel dissolution: a) along the central dark line (CDL) within carbonated apatite nanocrystals, b) at organic-rich precipitates and c) along high-angle grain boundaries. 3D maps of the atoms within hydroxyapatite nanocrystallites in sound and naturally-decayed human dental enamel reveal a higher concentration of Mg and Na in the CDL. The CDL is therefore thought to provide a pathway for the exchange of ions during demineralization and remineralization. Mg and Na enrichment of the CDL also suggests that it is associated with the ribbon-like organic-rich precursor in amelogenesis. Organic-rich precipitates and high-angle grain boundaries were also shown to be more vulnerable to corrosion while low-angle grain boundaries remained intact. This is attributed to the lower crystallinity in these regions.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atom probe tomography; Caries; Central dark line; Tooth enamel

Mesh:

Substances:

Year:  2019        PMID: 31978841     DOI: 10.1016/j.biomaterials.2019.119748

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  1 in total

1.  Exosome-transmitted lncRNA PCGEM1 promotes invasive and metastasis in gastric cancer by maintaining the stability of SNAI1.

Authors:  H-Y Piao; S Guo; Y Wang; J Zhang
Journal:  Clin Transl Oncol       Date:  2020-06-09       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.